The complications of controlling agency time discretion: FDA review deadlines and postmarket drug safety

American Journal of Political Science

Volumn 56, Issue 1, 2012, Pages 98-114

  Carpenter, Daniel ^a,b   Chattopadhyay, Jacqueline ^a   Moffitt, Susan ^c   Nall, Clayton ^d  

^a HARVARD UNIVERSITY   (United States)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c BROWN UNIVERSITY   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DECISION MAKING; DRUG APPROVAL; DRUG INDUSTRY; ECONOMICS; EDUCATION; ETHNOLOGY; FOOD AND DRUG ADMINISTRATION; HISTORY; LEGAL ASPECT; ORGANIZATION AND MANAGEMENT; POSTMARKETING SURVEILLANCE; PUBLIC HEALTH; UNITED STATES;

DECISION MAKING; DRUG APPROVAL; DRUG INDUSTRY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; ORGANIZATION AND ADMINISTRATION; PRODUCT SURVEILLANCE, POSTMARKETING; PUBLIC HEALTH; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84855922099     PISSN: 00925853     EISSN: 15405907     Source Type: Journal    
DOI: 10.1111/j.1540-5907.2011.00544.x     Document Type: Article

References (56)

1. Abbott, Alden. 1987. "Case Studies on the Costs of Federal Statutory and Judicial Deadlines." Administrative Law Review 39: 467-87.
2. Ando, Amy Whitenour. 1999. "Waiting to Be Protected under the Endangered Species Act: The Political Economy of Regulatory Delay." Journal of Law and Economics 42(1): 29-60.
3. Balla, Steven J., and John R. Wright. 2001. "Interest Groups, Advisory Committees, and Congressional Control of the Bureaucracy." American Journal of Political Science 45(4): 799-812.
4. Bawn, Kathleen. 1995. "Political Control versus Expertise: Congressional Choices about Administrative Procedures." American Political Science Review 89(1): 62-73.
5. Berenson, Alex. 2005. "Big Drug Makers See Sales Decline with Their Image." New York Times, November 14.
6. Blalock, Ann B., and Burt S. Barnow. 2001. "Is the New Obsession with Performance Management Masking the Truth about Social Programs?" In Quicker, Better, Cheaper? Managing Performance in American Government, ed. Dall W. Forsythe. New York: The Rockefeller Institute Press, 485-517.
7. Carpenter, Daniel P. 1996. "Adaptive Signal Processing, Hierarchy, and Budgetary Control in Federal Regulation." American Political Science Review 90(2): 283-302.
8. Carpenter, Daniel P. 2001. The Forging of Bureaucratic Autonomy: Reputations, Networks, and Policy Innovation in Executive Agencies, 1862-1928. Princeton, NJ: Princeton University Press.
9. Carpenter, Daniel P. 2002. "Groups, the Media, Agency Waiting Costs, and FDA Drug Approval." American Journal of Political Science 46(3): 490-505.
10. Carpenter, Daniel P. 2004. "Protection without Capture: Product Approval by a Politically Responsive, Learning Regulator." American Political Science Review 98(4): 613-31.
11. Carpenter, Daniel P. 2010. Reputation and Power: Organizational Image and Pharmaceutical Regulation in the FDA. Princeton, NJ: Princeton University Press.
12. Carpenter, Daniel P., Evan James Zucker, and Jerry Avorn. 2008. "Drug-Review Deadlines and Safety Problems." New England Journal of Medicine 358(13): 1354-61.
13. De Dreu, Carsten K. W. 2003. "Time Pressure and the Closing of the Mind in Negotiation." Organizational Behavior and Human Decision Processes 91(2): 280-95.
14. Fershtman, Chaim, and Daniel Seidmann. 1993. "Deadline Effects and Inefficient Delay in Bargaining with Endogenous Commitment." Journal of Economic Theory 60: 306-21.
15. Food and Drug Administration. 2007. Manual of Policies and Procedures: Center for Drug Evaluation and Research. MAPP 6020.3.
16. Fossett, James, Thomas Gais, and Frank J. Thompson. 2001. "Federalism and Performance Management: Health Insurance, Food Stamps, and the Take-Up Challenge." In Quicker, Better, Cheaper? Managing Performance in American Government, ed. Dall W. Forsythe. New York: The Rockefeller Institute Press, 207-44.
17. Furlong, Scott R. 1998. "Political Influence on the Bureaucracy: The Bureaucracy Speaks." Journal of Public Administration Research and Theory 8(1): 39-65.
18. Gersen, Jacob, and Anne O'Connell. 2008. "Deadlines in Administrative Law." University of Pennsylvania Law Review 156: 923.
19. Gneezy, Uri, et al. 2003. "Bargaining under a Deadline: Evidence from the Reverse Ultimatum Game." Games and Economic Behavior 45: 347-68.
20. Hansen, Ben B. 2004. "Full Matching in an Observational Study of Coaching for the SAT." Journal of the American Statistical Association 99(467): 609-18.
21. Ho, Daniel, Kosuke Imai, Gary King, and Elisabeth Stuart. 2007. "Matching as Nonparametric Preprocessing to Reduce Model Dependence in Parametric Causal Inference." Political Analysis 15: 199-236.
22. Hilts, Philip J. 2003. Protecting America's Health: The FDA, Business and One Hundred Years of Regulation. New York: Alfred Knopf.
23. Huber, John, and Charles R. Shipan. 2002. Deliberate Discretion: The Institutional Foundations of Bureaucratic Autonomy. New York: Cambridge University Press.
24. Huber, Oswald, and Urs Kunz. 2007. "Time Pressure in Risky Decision-Making: Effect on Risk Defusing." Psychology Science 49(4): 415-26.
25. Iacus, Stefano, Gary King, and Giuseppe Porro. 2011. "Multivariate Matching Methods That Are Monotonic Imbalance Bounding. Journal of the American Statistical Association 106(493): 345-61.
26. Kerwin, Cornelius. 2003. Rulemaking: How Government Agencies Write Law and Make Policy. Washington, DC: CQ Press.
27. Kosnik, Lea-Rachel D. 2006. "Sources of Bureaucratic Delay: A Case Study of FERC Dam Relicensing." Journal of Law, Economics, and Organization 22(1): 258-88.
28. Krause, George A. 2003. "Coping with Uncertainty: Analyzing Risk Propensities of SEC Budgetary Decisions, 1949-97." American Political Science Review 97(1): 171-88.
29. Krause, George A., and J. Kevin Corder. 2007. "Explaining Bureaucratic Optimism: Theory and Evidence from U.S. Executive Agency Macroeconomic Forecasts." American Political Science Review 101(1): 129-42.
30. Krause, George A., and James W. Douglas. 2006. "Does Agency Competition Improve the Quality of Policy Analysis? Evidence from OMB and CBO Fiscal Projections." Journal of Policy Analysis and Management 25(1): 53-74.
31. Lasser, Karen E., Paul D. Allen, Steffie J. Woolhandler, David U. Himmelstein, Sidney M. Wolfe, and David H. Bor. 2002. "Timing of New Black Box Warnings and Withdrawals for Prescription Medications." Journal of the American Medical Association 287(17): 2215-20.
32. Lewis, David E. 2008. The Politics of Presidential Appointments: Political Control and Bureaucratic Performance. Princeton, NJ: Princeton University Press.
33. Lexchin, Joel. 2005. "Drug Withdrawals from the Canadian Market for Safety Reasons, 1963-2004." Canadian Medical Association Journal 172(6): 765-67.
34. Mashaw, Jerry, and David Harfst. 1990. The Struggle for Auto Safety. Cambridge, MA: Harvard University Press.
35. McCullagh, Peter, and J. A. Nelder. 1989. Generalized Linear Models. London: Chapman and Hall.
36. McCubbins, Mathew D., Roger G. Noll, and Barry R. Weingast. 1987. "Administrative Procedures as Instruments of Political Control." Journal of Law, Economics, and Organization 3(2): 243-77.
37. McCubbins, Mathew D., Roger G. Noll, and Barry R. Weingast. 1989. "Structure and Process: Administrative Arrangements and the Political Control of Agencies. Virginia Law Review 75(2): 431-82.
38. Meadows, M. 2002. "Why Drugs Get Pulled Off the Market. FDA Consumer 36(1): 11-17.
39. Moe, Terry M. 1985. "Control and Feedback in Economic Regulation: The Case of the NLRB." American Political Science Review 79(4): 1094-1116.
40. Moffitt, Susan L. 2010. "Promoting Agency Reputation through Public Advice: Advisory Committee Use in the FDA." Journal of Politics 72(3): 880-93.
41. Moore, T., Psaty, B. M. and Furberg. C. D. 1998. "Time to Act on Drug Safety. Journal of the American Medical Association 279(19): 157-173.
42. Morgenstern, Richard. 1993. "Science, Engineering, and Regulation." In Keeping Pace with Science and Engineering, ed. Myron F. Uman. Washington, DC: National Academic Press, 243-50.
43. Nardinelli, Clark, Michael Lanthier, Robert Temple, and Daniel Carpenter. 2008. "Drug Review Deadlines and Safety Problems [Correspondence]." New England Journal of Medicine 359: 95-98.
44. Olson, Mary K. 1997. "Firm Characteristics and the Speed of FDA Approval." Journal of Economics and Management Strategy 6: 377-401.
45. Olson, Mary K. 2004. "Managing Delegation in the FDA: Reducing Delay in New-Drug Review." Journal of Health Politics, Policy, and Law 29(3): 397-430.
46. Olson, Mary K. 2008. "The Risk We Bear: The Effects of Review Speed and Industry User Fees on New Drug Safety." Journal of Health Economics 27(2): 175-200.
47. Sasich, L. D. 2000, September 15. "Comments before the Food and Drug Administration's Public Meeting on the Prescription Drug User Fee Act (PDUFA)." (HRG Publication # 1536). (accessed December 22, 2005).
48. Schierow, Linda-Jo. 2008. Pesticide Law: A Summary of the Statutes. Washington, DC: Congressional Research Service.
49. Spence, David B. 1999. "Managing Delegation Ex Ante: Using Law to Steer Administrative Agencies." Journal of Legal Studies 28(2): 413-59.
50. Therneau, Terry M., and Patricia M. Grambsch. 2000. Modeling Survival Data: Extending the Cox Model. New York: Springer-Verlag.
51. Ting, Michael M. 2001. "The 'Power of the Purse' and Its Implications for Bureaucratic Decision Making." Public Choice 106(3-4): 243-74.
52. United States Department of Health and Human Services Office of the Inspector General. 2003. FDA Review Process for New Drug Applications. OEI-01-01-00590. Washington, DC: Department of Health and Human Services.
53. United States Senate. 2004, November 18. "FDA, Merck, and Vioxx: Putting Patient Safety First?" Hearing before the Committee on Finance.
54. Weingast, Barry R. 1984. "The Congressional-Bureaucratic System: A Principal-Agent Perspective (with Applications to the SEC)." Public Choice 44: 147-91.
55. Whitford, Andrew B. 2005. "The Pursuit of Political Control by Multiple Principles." Journal of Politics 67(1): 29-49.
56. Yackee, Jason Webb, and Susan Webb Yackee. 2010. "Administrative Procedures and Bureaucratic Performance: Is Federal Rule-Making 'Ossified'?" Journal of Public Administration Research and Theory 20(2): 1-22.